Longboard Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	857	144	56	84
Market Cap Growth	-	156.33%	-33.20%	-
Enterprise Value	540	96	-11	-22
PE Ratio	-13.42	-2.64	-1.28	-3.02
PB Ratio	2.73	3.52	0.91	0.81
P/FCF Ratio	-14.69	-2.83	-1.47	-3.40
P/OCF Ratio	-14.69	-2.83	-1.47	-3.40
EV/EBITDA Ratio	-7.95	-1.76	0.24	0.80
EV/EBIT Ratio	-7.95	-1.76	0.24	0.80
EV/FCF Ratio	-8.70	-1.88	0.28	0.90
Debt / Equity Ratio	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	-0.07	-0.01	-0.02	-0.02
Debt / FCF Ratio	-0.08	-0.01	-0.02	-0.02
Quick Ratio	31.20	4.96	7.71	19.60
Current Ratio	31.43	5.14	7.97	19.91
Return on Equity (ROE)	-49.90%	-97.50%	-56.60%	-24.60%
Return on Assets (ROA)	-46.00%	-85.20%	-51.30%	-23.70%
Return on Capital (ROIC)	-19.80%	-137.11%	-72.01%	-26.81%
Earnings Yield	-6.76%	-37.83%	-78.30%	-33.09%
FCF Yield	-6.18%	-35.36%	-67.82%	-29.43%
Buyback Yield / Dilution	-73.06%	-32.51%	-19.02%	-278.34%
Total Shareholder Return	-73.06%	-32.51%	-19.02%	-278.34%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).